Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON - Crestani, B; Huggins, J T; Kaye, M (The Lancet Respiratory Medicine, 2019)
et al.